Covariation of amino acid positions in HIV-1 protease (Q47447715)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on September 30, 2003

Language	Label	Description	Also known as
English	Covariation of amino acid positions in HIV-1 protease	scientific article published on September 30, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14554082

Covariation of amino acid positions in HIV-1 protease (English)

1 reference

10.1016/S0042-6822(03)00484-7

https://api.crossref.org/works/10.1016/S0042-6822(03)00484-7

20 March 2024

Ronald Swanstrom

3

object named as

Ronald Swanstrom

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

author name string

Noah G. Hoffman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14554082

20 March 2024

Celia A. Schiffer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14554082

20 March 2024

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14554082

30 September 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14554082

20 March 2024

number of pages

13

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://doi.org/10.1016/s0042-6822(03)00484-7

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14554082

20 March 2024

https://api.elsevier.com/content/article/PII:S0042682203004847?httpAccept=text/xml

1 reference

10.1016/S0042-6822(03)00484-7

https://api.crossref.org/works/10.1016/S0042-6822(03)00484-7

20 March 2024

https://api.elsevier.com/content/article/PII:S0042682203004847?httpAccept=text/plain

1 reference

10.1016/S0042-6822(03)00484-7

https://api.crossref.org/works/10.1016/S0042-6822(03)00484-7

20 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14554082

314

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14554082

2

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14554082

536-548

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14554082

Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Covariability of V3 loop amino acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations between amino acids in the evolution of HIV type 1 protease sequences under indinavir therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precur

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389A

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of high-level resistance to human immunodeficiency virus type 1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitors of HIV-1 protease: a major success of structure-assisted drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A mutation in human immunodeficiency virus type 1 protease, N88S, that causes in vitro hypersensitivity to amprenavir

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900484-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0042-6822(03)00484-7

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14554082

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/14554082

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47447715&oldid=2107085996"